
浏览全部资源
扫码关注微信
纸质出版:2015
移动端阅览
高华平,陈永红,雷新,刘佳.锎-252中子内照射结合盆腔外照射治疗宫颈癌时全挡铅与半挡铅的长期疗效观察[J].陆军军医大学学报(原第三军医大学学报),2015,37(10):1040-1043.
Gao Huaping,Cheng Yonghong,Lei Xin,Liu Jia.Californium-252 neutron intracavitary brachytherapy combined with external beam radiotherapy for cervical cancer: long-term outcomes of whole vs partial lead block of the pelvic fields during whole pelvic field irradiation[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(10):1040-1043.
高华平,陈永红,雷新,刘佳.锎-252中子内照射结合盆腔外照射治疗宫颈癌时全挡铅与半挡铅的长期疗效观察[J].陆军军医大学学报(原第三军医大学学报),2015,37(10):1040-1043. DOI:
Gao Huaping,Cheng Yonghong,Lei Xin,Liu Jia.Californium-252 neutron intracavitary brachytherapy combined with external beam radiotherapy for cervical cancer: long-term outcomes of whole vs partial lead block of the pelvic fields during whole pelvic field irradiation[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(10):1040-1043. DOI:
目的 比较锎-252中子内照射结合外照射治疗宫颈癌时盆腔野照射全挡铅与半挡铅的治疗结果。 方法 分别选取2007年3月至2008年10月、2009年5-12月各115例经病理活检确诊的临床分期为Ⅱa~Ⅲb期宫颈鳞癌患者作为研究对象,按照临床分期、年龄、肿瘤直径、贫血程度进行配对研究,分为盆腔野中央全挡铅组(全挡组)和半挡铅组(半挡组)。患者采用全盆外照射中间穿插锎-252中子内照射的治疗方式。全盆外照射采用前后对穿野照射,2 Gy/(次·d),4~5次/周,照射24~36 Gy后,全挡组盆腔野中央挡铅4 cm,而半挡组为盆腔野中央骶3以下部分挡铅4 cm,继续照射至48~54 Gy。中子内照射宫旁A点总剂量40~42 Gy,1次/周,10~12 Gy/次,共进行4次。全盆外照及锎-252腔内照射结束后,对宫旁仍有侵犯的Ⅲb期患者宫旁小野补量8~12 Gy。用McNemar test的方法比较严重急性期并发症(≥G2)发生率和总体生存率、绝对无病生存率、局部控制率及严重晚期并发症(放射性直肠炎和膀胱炎)(≥G2)发生率的差异。平均随访60.2个月。 结果 半挡组患者急性期胃肠道反应、放射性直肠炎、放射性膀胱炎发生率略高于全挡组,但两组差异均无统计学意义(P0.05)。半挡组患者的总体生存率、绝对无病生存率和局部控制率略高于全挡组,而盆腔淋巴结复发率和晚期并发症发生率略低于全挡组,但两组差异均无统计学意义(P0.05)。 结论 宫颈癌患者根治性放疗盆腔外照射时全挡铅与半挡铅的疗效相近,建议尽可能采取半挡铅照射技术。
Objective To compare the long-term outcomes of whole lead block and partial lead block of the pelvic fields in the treatment of cervical cancer by external beam radiotherapy (EBRT) combined with californium-252 (252Cf) neutron intracavitary brachytherapy (ICBT). Methods From March 2007 to October 2008 and from May 2009 to December 2009
115 patients who had been diagnosed with stage ⅡA-ⅢB cervical squamous carcinoma by biopsy were enrolled and paired according to clinical stage
age
tumor size
and degree of anemia. They were divided into a whole lead block (WLB) group and a partial lead block (PLB) group during the whole pelvic field irradiation. For 252Cf ICBT
the total dose applied to point A was 40-42 Gy
9-11 Gy/f/w×4f. As for whole pelvis EBRT
anteroposterior (A-P) and posteroanterior (P-A) opposed fields were implemented. After 24-36 Gy irradiation
the pelvic field center was shielded with a 4 cm-thickness lead block in the WLB group
and the lead block was placed below S3 in the PLB group. The cumulative dose was 48-54 Gy. After EBRT
8-12 Gy irradiation should be boosted to the parametrial field if there was still parametrical invasion. McNemar test was employed to compare the severe acute complication (≥G2) incidence
overall survival rate
absolute disease-free survival rate
local control rate and severe late complication (radiation proctitis and radiation cystitis) (≥G2) incidence of the 2 groups. The mean follow-up time was 60.2 months. Results The incidences of acute gastrointestinal reaction
radiation proctitis
and radiation cystitis (≥G2) were higher in the WLB group than the PLB group (P0.05) though no significant difference was found. The overall survival rate
absolute disease-free survival rate
local control rate
pelvic lymph node recurrence rate and late complication incidence were higher in the WLB group thanin the PLB group. There were no statistically significant differences in the acute complication incidence
overall survival rate
absolute disease-free survival rate
local control rate
pelvic lymph node recurrence rate and late complication incidence between the 2 groups. Conclusion WLB of the pelvic fields has similiar efficiency as PLB in the treatment of cervical cancer by EBRT combined with 252Cf ICBT. So we recommend to employ the latter as much as possible.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621